CERo Therapeutics Holdings Inc [NASDAQ: CERO] plunged by -$1.69 during the normal trading session on Thursday and reaching a high of $0.404 during the day while it closed the day at $0.1.
CERo Therapeutics Holdings Inc stock has also loss -95.24% of its value over the past 7 days. However, CERO stock has declined by -98.76% in the 3 months of the year. Over the past six months meanwhile, it has lost -99.47% and lost -99.94% year-on date.
The market cap for CERO stock reached $0.11 million, with 1.19 million shares outstanding and 1.14 million shares in the current float. Compared to the average trading volume of 269.60K shares, CERO reached a trading volume of 45804905 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about CERo Therapeutics Holdings Inc [CERO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CERO shares is $22.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CERO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
D. Boral Capital have made an estimate for CERo Therapeutics Holdings Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 23, 2025.
CERO stock trade performance evaluation
CERo Therapeutics Holdings Inc [CERO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -95.24. With this latest performance, CERO shares dropped by -98.26% in over the last four-week period, additionally sinking by -99.47% over the last 6 months – not to mention a drop of -99.92% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CERO stock in for the last two-week period is set at 12.27, with the RSI for the last a single of trading hit 0.4548, and the three-weeks RSI is set at 0.4573 for CERo Therapeutics Holdings Inc [CERO]. The present Moving Average for the last 50 days of trading for this stock 4.8437, while it was recorded at 1.5110 for the last single week of trading, and 14.9982 for the last 200 days.
CERo Therapeutics Holdings Inc (CERO) Capital Structure & Debt Analysis
CERo Therapeutics Holdings Inc (CERO) Efficiency & Liquidity Metrics
CERo Therapeutics Holdings Inc (CERO) Efficiency & Liquidity Metrics
Earnings per share (EPS) analysis for CERo Therapeutics Holdings Inc [CERO] stock
With the latest financial reports released by the company, CERo Therapeutics Holdings Inc posted -61.71/share EPS, while the average EPS was predicted by analysts to be reported at -6.21/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -55.5. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CERO. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for CERo Therapeutics Holdings Inc go to 81.13%.
CERo Therapeutics Holdings Inc [CERO]: Institutional Ownership
There are presently around $16.63%, or 16.92%% of CERO stock, in the hands of institutional investors.
